‘It’s extraordinarily difficult to operate in a dynamic environment when it takes so long to get decisions’ by Steve Jones April 14, 2022April 29, 2024 In the second part of an exclusive interview with Cannabiz, ECS Botanics executive GM Nan-Maree Schoerie […]
GSK agreement ‘validates’ Satipharm strategy as Cann Group pins hopes on positive clinical trial by Steve Jones April 7, 2022April 29, 2024
Specialist firm urges TGA to rethink position on delta-8 THC by Martin Lane March 31, 2022April 29, 2024
Canopy duo back together at Creso but ‘with a new sheriff in town’ by Steve Jones March 24, 2022April 29, 2024
ANTG-Asterion merger hits the rocks but Canadian firm chases fresh Australian deal by Steve Jones March 17, 2022April 29, 2024
Medicinal cannabis regulations disguise solid progress in New Zealand by Carmen Doran March 11, 2022April 29, 2024
Bruce Linton: ‘The cool part of cannabis is there’s no Harvard book on it’ by Steve Jones March 10, 2022April 29, 2024
It’s time for the industry to walk the talk when conducting itself by Peter Crock March 3, 2022April 29, 2024
